Pepcid ac and Maxalt drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pepcid ac (famotidine) and Maxalt (rizatriptan benzoate). Common drug interactions include nausea among females and akathisia among males.

The phase IV clinical study analyzes what interactions people have when they take Pepcid ac and Maxalt. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Pepcid ac?

Pepcid ac has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 9,573 Pepcid ac users. Check the latest studies of Pepcid ac.

What is Maxalt?

Maxalt has active ingredients of rizatriptan benzoate. It is often used in migraine. eHealthMe is studying from 12,754 Maxalt users. Check the latest studies of Maxalt.



On Jul, 06, 2026

31 people who take Pepcid ac and Maxalt together, and have interactions are studied.

Pepcid ac and Maxalt drug interactions.

What are the common drug interactions of Pepcid Ac and Maxalt, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Back pain
  3. Arthralgia (joint pain)
  4. Depression
  5. Dizziness
  6. Dyspnoea (difficult or laboured respiration)
  7. Fall
  8. Fatigue (feeling of tiredness)
  9. Groin pain
  10. Headache (pain in head)

male:

  1. Akathisia (a movement disorder characterized by a feeling of inner restlessness)
  2. Anxiety
  3. Cardiac arrest
  4. Chronic kidney disease
  5. Dyskinesia (abnormality or impairment of voluntary movement)
  6. Hyperkalaemia (damage to or disease of the kidney)
  7. Insomnia (sleeplessness)
  8. Renal failure (kidney dysfunction)

What are the common drug interactions of Pepcid Ac and Maxalt, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Electrocardiogram qt prolonged

20-29:

n/a

30-39:

  1. Abnormal behaviour
  2. Asthenia (weakness)
  3. Dehydration (dryness resulting from the removal of water)
  4. Drug abuser
  5. Encephalopathy (functioning of the brain is affected by some agent or condition)
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Impaired self-care
  8. Incoherent (talking in a confused and unclear way)
  9. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  10. Multiple drug overdose

40-49:

  1. Application site erythema (redness of the skin at application site)
  2. Application site irritation
  3. Application site pruritus (application site severe itching of the skin)
  4. Application site scab (hard coating on the skin formed at application site)
  5. Asthenia (weakness)
  6. Cardiac arrest
  7. Drug hypersensitivity
  8. Hypertension (high blood pressure)
  9. Metastases to meninges (cancer spreads to meninges)
  10. Pruritus (severe itching of the skin)

50-59:

  1. Panic attack
  2. Abdominal discomfort
  3. Chronic kidney disease
  4. Complex regional pain syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet))
  5. Irritable bowel syndrome
  6. Renal failure (kidney dysfunction)
  7. Anxiety
  8. Breast cancer
  9. Muscle spasms (muscle contraction)
  10. Nausea (feeling of having an urge to vomit)

60+:

  1. Cardiac arrest
  2. Chronic kidney disease
  3. Hyperkalaemia (damage to or disease of the kidney)
  4. Renal failure (kidney dysfunction)
  5. Nephrogenic anaemia (anaemia due to kidney disease)
  6. Renal tubular necrosis (death of kidney tubules)

What are the existing conditions these people have? *

  1. Asthma: 10 people, 32.26%
  2. Headache (pain in head): 9 people, 29.03%
  3. Cough: 7 people, 22.58%
  4. Constipation: 7 people, 22.58%
  5. Allergic Rhinitis: 7 people, 22.58%
  6. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 16.13%
  7. Immunodeficiency Common Variable: 5 people, 16.13%
  8. Pain: 4 people, 12.90%
  9. Gastrointestinal Motility Disorder (abnormal intestinal contractions): 4 people, 12.90%
  10. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 9.68%

* Approximation only. Some reports may have incomplete information.

Do you take Pepcid ac and Maxalt?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pepcid ac and Maxalt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pepcid ac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Maxalt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pepcid ac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Maxalt and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on famotidine and rizatriptan benzoate (the active ingredients of Pepcid ac and Maxalt, respectively), and Pepcid ac and Maxalt (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: